The detectives were indicted on Monday on charges that they sexually assaulted an 18-year-old woman who was handcuffed inside a police van in Brooklyn.
NYS Entity Status
NYS Filing Date
APRIL 14, 2014
NYS DOS ID#
NYS Entity Type
FOREIGN LIMITED PARTNERSHIP
2014 - OLD ORCHARD CAPITAL MANAGEMENT LP
Around the Web
- Two New York Detectives Are Charged With Raping Teenager in Custody
By ALAN FEUER - Monday Oct 30, 2017
- Bacon’s Moore Capital fires workers amid hedge-fund woes
By Carleton English - Thursday Jul 13, 2017
Louis Bacon’s hedge fund just got a little leaner. The billionaire’s Moore Capital Management cut 30 jobs at its New York and London offices, a spokesperson for the firm confirmed. Moore Capital’s headcount reduction accounts for 7 percent of the $13.4 billion fund’s 427 person workforce. “Like many firms in our industry, Moore Capital Management...
- Hedge fund manager closes firm to pursue politics
By Carleton English - Tuesday Sep 19, 2017
Connecticut needs a hedge fund manager to solve its problems. That’s according to 48-year-old David Stemerman, who said Tuesday he will shut down his hedge fund, Conatus Capital, to explore a gubernatorial run — even though the state’s fiscal woes have been partly blamed on the downturn in the hedge fund industry. “Connecticut … is...
- Josh McCown did not slow the countdown to a QB change
By Howie Kussoy - Sunday Sep 10, 2017
ORCHARD PARK — Josh McCown needs to do more if the Jets are ever going to win this season. The 38-year-old veteran will need to do much more if he wants to keep his starting job. McCown was accurate, but largely ineffective in his first game with the Jets, completing 26-of-39 passes for 187 yards,...
- Acorda Takes Another Hit, Reports Patient Deaths in Parkinson’s Study
By Ben Fidler - Wednesday Nov 15, 2017
Acorda Therapeutics’ rebuilding plan just suffered another setback, leaving the fate of one of the experimental Parkinson’s disease drugs that is closest to market unclear. Ardsley, NY-based Acorda (NASDAQ: ACOR) said Wednesday morning that it has seen troubling safety problems in a Phase 3 trial of its experimental Parkinson’s disease drug tozadenant. Acorda reported cases […]
- Martin Shkreli is found guilty of fraud
By Stephanie Clifford and Colin Moynihan - Friday Aug 4, 2017
NEW YORK — Martin Shkreli, accused of defrauding his hedge fund investors and a pharmaceutical company, was convicted on three of eight counts on Friday, after a five-week trial in U.S. District Court in Brooklyn, N.Y.Shkreli was accused of securities and wire fraud related to two hedge funds he ran, MSMB Capital and MSMB Healthcare.The prosecution brought forth an “avalanche” of evidence, as prosecutor Jacquelyn Kasulis put it in her rebuttal argument, that included a threatening letter he sent to the wife of a former employee, statements he sent to MSMB investors showing great returns at the same time he had no money in fund accounts, three versions of a backdated agreement to make it look as if MSMB Capital had invested in Retrophin when it had not, as well as claims about assets under management that were wildly out of line with his actual fund size.